<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967197</url>
  </required_header>
  <id_info>
    <org_study_id>2020-8355</org_study_id>
    <nct_id>NCT03967197</nct_id>
  </id_info>
  <brief_title>Lidocaine Before Esophageal Manometry and Ambulatory pH Monitoring</brief_title>
  <official_title>Is Lidocaine Useful Before Esophageal Manometry and Ambulatory pH Monitoring? A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial comparing esophageal manometry and ambulatory pH monitoring
      test tolerance in the presence versus in the absence of topical lidocaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Conventionally, topical nasopharyngeal anesthesia is applied to improve the tolerance of
      esophageal manometry and ambulatory pH monitoring. However, there is currently no data to
      support this practice. This randomized controlled trial of lidocaine versus placebo applied
      before these tests will evaluate the benefit of topical lidocaine anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 6, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of pain during catheter insertion</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global patient satisfaction</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire (on scale of 1 to 5, 5 being highest satisfaction score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of other complications during catheter insertion</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of complications during test recording</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the lidocaine intervention will receive 2 sprays of lidocaine hydrochloride 10% in each nostril 3-5 minutes before their test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (Saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to placebo will receive 2 sprays of physiological saline in each nostril 3-5 minutes before their test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline spray</intervention_name>
    <description>Physiologic saline spray</description>
    <arm_group_label>Placebo (Saline)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride</intervention_name>
    <description>Lidocaine hydrochloride 10% spray</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patients undergoing esophageal manometry or ambulatory pH monitoring at our center
        who are able to read and consent to participate in the study.

        Exclusion Criteria:

          -  Patients &lt; 18 years

          -  Incapacity to provide consent

          -  History of lidocaine allergy

          -  Current pregnancy

          -  Previous esophageal manometry or ambulatory pH monitoring in the last 14 days

          -  Previous participation in the study

          -  Severe cirrhosis (Child-Pugh C)

          -  Severe chronic kidney disease (eGFR&lt;30 mL/min/1.73m2)

          -  Severe heart failure (New York Heart Association Functional Classification 3-4)

          -  Severe respiratory failure (dyspnea or oxygen-dependent at rest)

          -  Any active severe incapacitating chronic or acute medical disease

          -  Active hospitalization

          -  Ulcerated, atrophic, infected or recently burned (in the last 30 days) nasopharynx

          -  Recent surgery involving the nasopharynx (in the last 30 days)

          -  Severe chronic pain (ex. regular daily use of opioids)

          -  Previous stroke or any neurological lesion with resulting current sensory deficit

          -  Major neurocognitive disorder

          -  Any active severe incapacitating chronic or acute psychiatric disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>September 8, 2019</last_update_submitted>
  <last_update_submitted_qc>September 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>manometry</keyword>
  <keyword>pH monitoring</keyword>
  <keyword>lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

